Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pong, Terrence ^a,b,c   Scherrer Crosbie, Marielle ^a   Atochin, Dmitriy N ^a   Bloch, Kenneth D ^a   Huang, Paul L ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; KNOCKOUT MOUSE; MOUSE; NONHUMAN; REPERFUSION INJURY;

ANIMALS; CONTRAST MEDIA; CORONARY CIRCULATION; ENZYME ACTIVATION; ISCHEMIC POSTCONDITIONING; KINETICS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTANT PROTEINS; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84908191432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085946     Document Type: Article

References (38)

1. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, et al. (2004) Post-conditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62: 74-85. (Pubitemid 38326813)
2. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, et al. (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-588. (Pubitemid 36885888)
3. Bolli R (2007) Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 292: H19-27.
4. Ludman AJ, Yellon DM, Hausenloy DJ (2010) Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 3: 35-38.
5. Mewton N, Ivanes F, Cour M, Ovize M (2010) Postconditioning: from experimental proof to clinical concept. Dis Model Mech 3: 39-44.
6. Sanada S, Komuro I, Kitakaze M (2011) Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 301: H1723-1741.
7. Gerczuk PZ, Kloner RA (2012) An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 59: 969-978.
8. Laskey WK, Yoon S, Calzada N, Ricciardi MJ (2008) Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 72: 212-220.
9. Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, et al. (2010) Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 3: 34-41.
10. Ma XJ, Zhang XH, Li CM, Luo M (2006) Effect of postconditioning on coronary blood flow velocity and endothelial function in patients with acute myocardial infarction. Scand Cardiovasc J 40: 327-333.
11. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, et al. (2008) Long-term benefit of postconditioning. Circulation 117: 1037-1044.
12. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, et al. (2005) Postconditioning the human heart. Circulation 112: 2143-2148. (Pubitemid 41475808)
13. Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8: 619-629.
14. Lefer DJ, Bolli R (2011) Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. J Cardiovasc Pharmacol Ther 16: 332-339.
15. Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, et al. (2011) New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 124: 1172-1179.
16. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD (2008) cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 77: 344-352. (Pubitemid 351197643)
17. Kitakaze M, Hori M (1998) It is time to ask what adenosine can do for cardioprotection. Heart Vessels 13: 211-228. (Pubitemid 29349384)
18. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, et al. (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
19. Otani H (2009) The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal 11: 1913-1928.
20. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, et al. (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87: 406-423.
21. Scherrer-Crosbie M, Liel-Cohen N, Otsuji Y, Guerrero JL, Sullivan S, et al. (2000) Myocardial perfusion and wall motion in infarction border zone: assessment by myocardial contrast echocardiography. J Am Soc Echocardiogr 13: 353-357. (Pubitemid 30322433)
22. Raher MJ, Thibault H, Poh KK, Liu R, Halpern EF, et al. (2007) In vivo characterization of murine myocardial perfusion with myocardial contrast echocardiography: validation and application in nitric oxide synthase 3 deficient mice. Circulation 116: 1250-1257. (Pubitemid 47517536)
23. Kashiwagi S, Atochin DN, Li Q, Schleicher M, Pong T, et al. (2013) eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun 431: 284-290.
24. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605.
25. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, et al. (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601.
26. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
27. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, et al. (1999) Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276: H1567-1573. (Pubitemid 29246543)
28. Kass M, Witkin A, Terzopoulos D (1988) Snakes: active contour models International Journal of Computer Vision 1: 321-331.
29. Yezzi A, Jr., Kichenassamy S, Kumar A, Olver P, Tannenbaum A (1997) A geometric snake model for segmentation of medical imagery. IEEE Trans Med Imaging 16: 199-209. (Pubitemid 127762931)
30. Ayata C, Dunn AK, Gursoy OY, Huang Z, Boas DA, et al. (2004) Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab 24: 744-755. (Pubitemid 38880219)
31. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, et al. (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97: 473-483. (Pubitemid 28090220)
32. Kaul S, Kelly P, Oliner JD, Glasheen WP, Keller MW, et al. (1989) Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol 13: 468-482. (Pubitemid 19055675)
33. Reffelmann T, Kloner RA (2006) The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 101: 359-372. (Pubitemid 44275869)
34. Lacerda L, Somers S, Opie LH, Lecour S (2009) Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84: 201-208.
35. Shaul PW (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64: 749-774.
36. Huang PL (2005) Unraveling the links between diabetes, obesity, and cardiovascular disease. Circ Res 96: 1129-1131.
37. Schleicher M, Yu J, Murata T, Derakhshan B, Atochin D, et al. (2009) The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2: ra41.
38. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, et al. (2007) The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117: 1961-1967. (Pubitemid 47036330)